These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7774654)

  • 21. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K; Schur PH; Ruddy S
    Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
    Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
    Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
    Sundsmo JS; Wood LM
    J Immunol; 1981 Sep; 127(3):877-80. PubMed ID: 6911148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K; Schur PH; Ruddy S
    J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.
    Jelezarova E; Vogt A; Lutz HU
    Biochem J; 2000 Jul; 349(Pt 1):217-23. PubMed ID: 10861231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping of the properdin-binding site in the third component of complement.
    Lambris JD; Alsenz J; Schulz TF; Dierich MP
    Biochem J; 1984 Jan; 217(1):323-6. PubMed ID: 6696726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement.
    Junker A; Baatrup G; Svehag SE; Wang P; Holmström E; Sturfelt G; Sjöholm AG
    Scand J Immunol; 1998 May; 47(5):481-6. PubMed ID: 9627133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
    Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C3b2-IgG complexes retain dimeric C3 fragments at all levels of inactivation.
    Jelezarova E; Luginbuehl A; Lutz HU
    J Biol Chem; 2003 Dec; 278(51):51806-12. PubMed ID: 14527961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
    Zhang MX; Klein B
    Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properdin binding to complement activating surfaces depends on initial C3b deposition.
    Harboe M; Johnson C; Nymo S; Ekholt K; Schjalm C; Lindstad JK; Pharo A; Hellerud BC; Nilsson Ekdahl K; Mollnes TE; Nilsson PH
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E534-E539. PubMed ID: 28069958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells.
    Tsuji S; Kaji K; Nagasawa S
    J Biochem; 1994 Oct; 116(4):794-800. PubMed ID: 7883753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
    Schreiber RD; Götze O; Müller-Eberhard HJ
    J Exp Med; 1976 Oct; 144(4):1062-75. PubMed ID: 62010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin.
    Vuagnat BB; Mach J; Le Doussal JM
    Mol Immunol; 2000 Jun; 37(8):467-78. PubMed ID: 11090881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.
    Agarwal S; Specht CA; Haibin H; Ostroff GR; Ram S; Rice PA; Levitz SM
    mBio; 2011; 2(5):. PubMed ID: 21878570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and characterisation of the thrombospondin type I repeats of human properdin.
    Perdikoulis MV; Kishore U; Reid KB
    Biochim Biophys Acta; 2001 Aug; 1548(2):265-77. PubMed ID: 11513971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation.
    Xu W; Berger SP; Trouw LA; de Boer HC; Schlagwein N; Mutsaers C; Daha MR; van Kooten C
    J Immunol; 2008 Jun; 180(11):7613-21. PubMed ID: 18490764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of properdin in zymosan- and Escherichia coli-induced complement activation.
    Harboe M; Garred P; Lindstad JK; Pharo A; Müller F; Stahl GL; Lambris JD; Mollnes TE
    J Immunol; 2012 Sep; 189(5):2606-13. PubMed ID: 22851705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.